Boston Financial & Equity started off 2020 by closing a lease transaction for a Seattle based drug discovery company. The company founded in 2011, originally funded by family and friends, has raised over $29 million to date. Their approach to drug discovery accelerates the timeline and increases manufacturing efficiencies, reducing the costs to the Biopharmaceutical industry. The company, although they have less than a year of cash, and minimal revenues, has agreements with three of the largest pharma companies. We leased them a $725,000 fermentation system.